AI-ECG to assess heart failure risk after afib ablation
Part of Heart & circulation clinical trials.
This trial uses an AI tool to analyze your heart's electrical signals (ECG) to better understand your risk of heart failure and how well your heart recovers after a procedure called catheter ablation for atrial fibrillation. It may help guide your treatment if you have early signs of heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have atrial fibrillation that comes and goes or is constant.
- This is your first catheter ablation for atrial fibrillation.
- In the last 3 months, your heart's pumping strength was between 41% and 49%.
- You have at least one sign of early heart failure, such as a certain blood test result or trouble breathing with activity.
- You have not had a previous catheter ablation for atrial fibrillation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using an artificial intelligence (AI) system to read your electrocardiogram (ECG, a heart rhythm test) can better evaluate your heart's structure and function, helping manage atrial fibrillation (AF). You may qualify if you have AF and need an echocardiogram (ultrasound of the heart).
This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.
This study compares two treatments for people with atrial fibrillation (an irregular heartbeat) and heart failure with preserved ejection fraction (a type of heart failure where the pumping function is still normal). You would receive either catheter ablation (a procedure to correct the heart's rhythm) or anti-arrhythmia drugs, to see which works better to improve your symptoms.
This trial tests two different ablation techniques to treat a type of irregular heartbeat that doesn't go away on its own. It aims to find which approach works better and is safer.
This trial tests whether an artificial intelligence (AI) system can help choose the best patients for a procedure called catheter ablation for atrial fibrillation (AF). It may improve which people benefit most while keeping safety in mind.
This trial tests whether an artificial intelligence-enhanced ECG (called SmartECG) can detect hidden atrial fibrillation better than usual care in people who have symptoms like a racing heart or dizziness. If you qualify, you'll be randomly assigned to get the AI-enhanced test or standard monitoring, and followed to see if AF is found.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.